Covidien Declares Quarterly Cash Dividend and Announces Stock Buyback.DUBLIN, Ireland -- Covidien (NYSE NYSE See: New York Stock Exchange : COV COV Composés Organiques Volatiles (French) COV Compuestos Orgánicos Volátiles (Spanish: Volatile Organic Compounds) COV Coefficient of Variation COV City of Villians (game) ; BSX BSX Bermuda Stock Exchange BSX Bandai Satellaview-X BSX Bicycle Super-X (Cross) : COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on February 27, 2009, to shareholders of record on February 6, 2009. Covidien also announced that its Board of Directors has authorized au·thor·ize tr.v. au·thor·ized, au·thor·iz·ing, au·thor·iz·es 1. To grant authority or power to. 2. To give permission for; sanction: a program to purchase up to $300 million of the Company's common shares from time to time, based on market conditions, to partially offset dilution related to equity compensation plans. ABOUT COVIDIEN LTD LTD 1 Laron-type dwarfism 2 Leukotriene D 3 Long-term depression, see there 4. Long-term disability . Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion